# Study of NeuroAid In Enhancing Recovery After Stroke

> **NCT00721825** · PHASE2 · COMPLETED · sponsor: **Moleac Pte Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Stroke
- Cerebral Infarction

## Interventions

- **DRUG:** Neuroaid
- **DRUG:** Neuroaid matched Placebo

## Key facts

- **NCT ID:** NCT00721825
- **Lead sponsor:** Moleac Pte Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2008-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00721825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00721825, "Study of NeuroAid In Enhancing Recovery After Stroke". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00721825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*